We talk about molecular testing with Dr. Andrzej Tysarowski, head of the Department of Genetic and Molecular Cancer Diagnostics at the National Cancer Institute.
Poland is among the countries where the scale of opioid abuse is the smallest, but that doesn't mean the problem doesn't exist. During Thursday's meeting of the Health Committee, deputies reviewed the ministry's information on the subject. Which drugs are of greatest concern?
W poniedziałek 1 lipca kolejne posiedzenie Rady Przejrzystości.
"Consideration of information from the Minister of Health on the sale of opioids in Poland and plans to prevent illegal access to narcotics of this kind."
Prostate cancer is the most common cancer in men and one of the most dangerous. The medical advances that have been made in the treatment and diagnosis of prostate cancer are enormous. Systemic changes must keep up with it, but for that, we need to change the way we think and approach prostate...
Health Ministry reminds: As of August 1, 2024, the P1 system will require the entry of information on the duration of use and amount of drug to be administered when issuing annual prescriptions.
The Agency for Medical Research (ABM) is launching a competition for non-commercial clinical trials and research experiments in the field of oncology, allocating PLN 600 million for projects aimed at changing cancer diagnosis and therapy in Poland.
Deputy Health Minister Marek Kos takes over from Maciej Miłkowski. What hopes and expectations do patients have? We ask Stanislaw Maćkowiak, president of the Federation of Polish Patients.
On Monday, June 24, the next meeting of the Transparency Council.
Health Minister Izabela Leszczyna announced at a press conference on the July list of reimbursed drugs who will replace Maciej Miłkowski.
Maksymilian Swiniarski has been appointed the new chairman of the board of directors of TZF Polfa S.A. The decision to appoint Maksymilian Swiniarski to this position was made by the Company's Supervisory Board after a qualification procedure, for which 19 candidates and candidates applied. The...
AOTMiT has completed work on developing a list concerning drugs for cardiovascular indications, requiring use longer than 30 days for a specific clinical condition and recommended in clinical management guidelines, for which the applicant has not yet submitted an application for reimbursement and...
On Monday, June 17, the next meeting of the Transparency Council.
Biogen obtains marketing approval from the European Commission for the drug tofersen, the first therapeutic solution for the treatment of a rare, genetic form of ALS. Amyotrophic lateral sclerosis (ALS) with a mutation in the SOD1 gene is a devastating, fatal and extremely rare genetic form of...
Up to half of patients with severe symptomatic mitral valve regurgitation are not referred for surgery because of the risks of the procedure. For them, an innovative tricuspid valve made from porcine pericardium may be a chance for treatment. - This is a chance of life for this group of patients,...
- Those who are best prepared will gain, because it is necessary to prepare properly for the new regulations. Those who oversleep this moment, who will not keep up with the new regulations, will lose," says attorney Dariusz Tarabasz of Czyzewscy Law Firm in an interview with Medexpress,...
– Leki ukierunkowane molekularnie znajdują zastosowanie w praktyce klinicznej, nie tylko w leczeniu chorych na zaawansowane raki płuca, przede wszystkim niedrobnokomórkowe, ale i w leczeniu uzupełniającym. Diagnostyka molekularna ma więc ogromne znaczenie – mówi w wywiadzie dla Medexpressu prof....
On Monday, June 3, the next meeting of the Transparency Council.
The OJ of the Ministry of Health published an Announcement of the Minister of Health dated May 23, 2024 on the list of medicinal products, foodstuffs for special nutritional purposes and medical devices at risk of unavailability on the territory of the Republic of PolandThe list contains 238...
On Tuesday, June 4, the next meeting of the Transparency Council.
An interview with Dominik Zuk, a hybrid AI data management specialist.
Some seniors have to go to the doctor twice to get a prescription entitling them to free drugs. This happens when the specialist does not have the authority to issue free prescriptions with code "S" for seniors 65 plus, experts from the Federation of the Zielonogórskie Agreement point out.
The Ministry of Health has published the new composition of the Economic Commission.
The Association of Employers of Innovative Pharmaceutical Companies INFARMA has just published its annual "Access Gap" report, summarizing Polish patients' access to innovative therapies. How would you comment on the latest results?According to data published by INFARMA in its third Access GAP...
An interview with Prof. Piotr Kuna of the Medical University of Lodz.
Access to innovative therapies and diagnostic solutions in Poland improved again last year, mainly due to oncology drugs and those used for rare diseases. The least progress is in chronic diseases, although clinicians stress that there has been tremendous progress in this area as well in recent...
The Announcement of the President of the National Health Fund on the implementation of the pilot program on pharmacist services for reproductive health has been published. The President of the National Health Fund stresses that according to the Law on the Pharmaceutical Profession, a pharmacist...
On Monday, May 20, the next meeting of the Transparency Council.
Interview with Prof. Tomasz Szczepanski, president of the Polish Society of Pediatric Oncology and Hematology.
On Monday, May 13, the next meeting of the Transparency Council.
© 2023 Medexpress. All Rights Reserved